activin
alk1
antitumor
bmp9
cohorts
correlative
dalantercept
diuretic
edema
escalating
evaluable
fatigue
formerly
gross
hemorrhage
morphogenetic
perforations
pharmacodynamic
pharmacodynamics
pharmacokinetics
proteinuria
recistv1
refractory
responded
subcutaneously
telangiectasia
tolerability
toxicities
underway
|